Natural History Study of Factor IX Treatment and Complications

UnknownOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

December 31, 2021

Conditions
Factor IX Deficiency
Interventions
OTHER

Standard care with blood and urine sample collection

Trial Locations (1)

46260

Indiana Hemophilia & Thrombosis Center, Indianapolis

All Listed Sponsors
collaborator

Indiana Hemophilia &Thrombosis Center, Inc.

OTHER

collaborator

Bioverativ Therapeutics Inc.

INDUSTRY

collaborator

Swedish Orphan Biovitrum

INDUSTRY

lead

Skane University Hospital

OTHER